Finally we get a kind of almost bad week! Nasdaq 100 down 1%! Remember your stop losses if you use them, remember your plan for how to handle risk and your promise to yourself to have some discipline, and remember that when everything falls at once, that’s when you get to buy the things you […]
Articles
Today we’ve got a bonanza of content for my favorite people (yes, that’s you!) — a couple quick teaser solutions to close out the week, which morphs right into one little transaction in my portfolio, and then an update on a few other things that are going on with Real Money Portfolio stocks. Ready? OK, […]
I like reading Howard Lindzon, a hedge fund/venture capital guy who became a widely-followed trend pundit and co-founded StockTwits, and he now has a newsletter in partnership with Agora… so Gumshoe readers were curious about what he’s selling, and, frankly, so was I. Let’s dig in, shall we? Lindzon is a prolific opiner, so you […]
Monthly stock-picking newsletter from Howard Lindzon, the hedge fund/VC investor and StockTwits founder who invests in and writes about his “trend ideas,” which tends to mean tech/growth stocks.
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
I was holding it as "cash with maybe some potential benefit," but came up with a better use for the cash. I didnt' sell...
This was a fantastic letter and an incredible bargain at 79$ per year. A real shame he closed it down. However, for sign...
Howard Lindzon sent out a note to those of us who subscribed and said that he's discontinuing the newsletter as it was m...
That's what I'm seeing on the CDC site too - diabetes. And Eli Lilly bought a glucagon nasal spray from a small company ...
And now Citron has turned against Twitter (TWTR) at ~$30-32, after being bullish somewhere in the $22-24 range back in J...